BIOCRYST PHARMACEUTICALS, INC.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2016 | 91.3% | -184.4% | -209.3% |
| FY2017 | 95.5% | -227.9% | -261.2% |
| FY2018 | — | -456.2% | -490.3% |
| FY2019 | 92.4% | -203.7% | -223.0% |
| FY2020 | 91.3% | -981.1% | -1,026.4% |
| FY2021 | 95.4% | -113.1% | -117.1% |
| FY2022 | 97.6% | -54.8% | -91.2% |
| FY2023 | 98.6% | -31.3% | -68.4% |
| FY2024 | 97.3% | -0.6% | -19.7% |
| FY2025 | 97.8% | 39.0% | 30.2% |